Though this study reported that central nervous system (CNS) metastases were observed at comparable frequencies in both BRCA1- and BRCA2-mutation carriers, when adjusting for breast cancer subtypes, a significant association with CNS metastases was primarily observed in BRCA2 mutation carriers. The gene discussed is BRCA2; the disease is breast carcinoma.